High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges

Anton W Langerak, Monika Brüggemann, Frédéric Davi, Nikos Darzentas, Jacques J M van Dongen, David Gonzalez, Gianni Cazzaniga, Véronique Giudicelli, Marie-Paule Lefranc, Mathieu Giraud, Elizabeth A Macintyre, Michael Hummel, Christiane Pott, Patricia J T A Groenen, Kostas Stamatopoulos, EuroClonality-NGS Consortium

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)


Analysis and interpretation of Ig and TCR gene rearrangements in the conventional, low-throughput way have their limitations in terms of resolution, coverage, and biases. With the advent of high-throughput, next-generation sequencing (NGS) technologies, a deeper analysis of Ig and/or TCR (IG/TR) gene rearrangements is now within reach, which impacts on all main applications of IG/TR immunogenetic analysis. To bridge the generation gap from low- to high-throughput analysis, the EuroClonality-NGS Consortium has been formed, with the main objectives to develop, standardize, and validate the entire workflow of IG/TR NGS assays for 1) clonality assessment, 2) minimal residual disease detection, and 3) repertoire analysis. This concerns the preanalytical (sample preparation, target choice), analytical (amplification, NGS), and postanalytical (immunoinformatics) phases. Here we critically discuss pitfalls and challenges of IG/TR NGS methodology and its applications in hemato-oncology and immunology.

Original languageEnglish
Pages (from-to)3765-3774
Number of pages10
JournalJournal of Immunology
Issue number10
Early online date17 Apr 2017
Publication statusPublished - 15 May 2017
Externally publishedYes


  • Journal Article

Fingerprint Dive into the research topics of 'High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges'. Together they form a unique fingerprint.

Cite this